Key to a woman’s heart (condition)?
Aug. 10, 2012—Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.
Ancestry impacts smoking risk for lungs
Aug. 7, 2012—Smoking is more detrimental to lung function in individuals with high proportions of African ancestry.
Gene’s impact on ‘good’ cholesterol could affect heart disease risk
Jul. 12, 2012—A genetic variant may help keep an individual’s “good” cholesterol in check.
Long live the therapeutic stem cells
May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
New clue to ADHD
May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
Better blood pressure-reducing drugs?
Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
New tool hooks heart failure drugs
Apr. 6, 2012—A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.
Combo combats dizziness
Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.
Stem cells take heart
Feb. 20, 2012—Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle.
Fishing for heart attack repair tools
Jan. 5, 2012—Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool: zebrafish. The researchers visually screened...
Meds’ benefits differ in dialysis patients
Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...
Move out, cholesterol
Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.